This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A randomized, double-blind, placebo controlled tri...
Clinical trial

A randomized, double-blind, placebo controlled trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of lixisenatide in paediatric (10 - 17 years old) and adult patients with type 2 diabetes

Read time: 1 mins
Last updated:21st Mar 2012
To investigate the effects of two single subcutaneous lixisenatide doses (5 and 10 �g) as compared to placebo in reducing postprandial glucose (PPG) in type 2 diabetic paediatric population (10-17 years old) and adults as controls
Category Value
Study start date 2012-03-21

View full details